CXCL12 and atherosclerosis: Moreover, the CXCL12/CXCR4 interaction activates the GSK-3β/β-cateninT120/TCF21 signalling pathway to inhibit ABCA1-dependent cholesterol efflux from macrophages to Apo-A1 and aggravate atherosclerosis [84,85].